Vanguard Personalized Indexing Management
MGNX icon

Vanguard Personalized Indexing Management’s MacroGenics MGNX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.8K Sell
14,888
-264
-2% -$999 ﹤0.01% 2104
2026
Q1 		$43.8K Buy
15,152
+2,372
+19% +$5.06K ﹤0.01% 2069
2025
Q4 		$20.6K Buy
12,780
+2,201
+21% +$3.46K ﹤0.01% 1938
2025
Q3 		$17.8K Buy
+10,579
New +$17.1K ﹤0.01% 1967

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Personalized Indexing Management's MGNX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its MacroGenics (MGNX) stake by 1.7% in Q2 2026, selling an estimated $999 and leaving 14,888 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2104.

Vanguard Personalized Indexing Management first reported a position in MGNX in Q3 2025 and has held it in 4 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 14,888 shares of MacroGenics worth $68.8K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 264 MacroGenics shares in Q2 2026, an estimated $999.
  • MacroGenics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2104 holding.
  • Vanguard Personalized Indexing Management first reported a position in MacroGenics in Q3 2025 and has held it in 4 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.